Elizabeth M. Jaffee and Philip D. Greenberg opened AACR IO 2026 with a look at cancer vaccines and the...
Putting off a routine medical examination for a few months might seem, to many, as routine as the examination...
Editor’s note: This story, written by Anna Azvolinsky, first appeared in Leading Discoveries, a magazine and website that raises...
The COVID-19 pandemic has taken a devastating toll, with 5.8 million deaths worldwide, including nearly 1 million in the...
For the first Editors’ Picks collection of 2022, the editors of the AACR journals highlighted studies that assessed the...
In the United States, advances in cancer research have dramatically improved outcomes for children diagnosed with cancer. While pediatric...
Margaret Foti, PhD, MD (hc), chief executive officer of the American Association for Cancer Research (AACR), along with other...
As recently as 10 years ago, the words “machine learning” evoked thoughts of sentient robots and fears of the...
Despite tremendous progress against cancer in the past few decades, not all Americans have benefited equally from advances in...
Seven immune checkpoint inhibitors, targeting the PD-1, PD-L1, or CTLA-4 proteins, are currently approved for the treatment of cancer....
The most recent edition of The Cancer Letter features an op-ed from AACR President David A. Tuveson, MD, PhD,...